| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8d8cf143a83869e2af349d0113af3bd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-80 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14 |
| filingDate |
2016-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8444e960ef0904b4b98c888ea373f29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c2fe97332b4af475b8075d99a3a4ed6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef0061018eed0f1c6d971844cf52c02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9275cead16331b169e961c6b9ce34554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae729c707987667f0403e95838b82630
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e749eb9052b05651e71efbd8015f59ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c4c575ef0eb4ddcc8f326ac512eaa30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18cf89c3fdece0ca9f1f203f70df8b53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6345ad721f1cd48f56102ab60bcb28f9 |
| publicationDate |
2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016133888-A1 |
| titleOfInvention |
Compounds for treating respiratory syncytial virus infections |
| abstract |
The present disclosure provides compounds useful in the treatment of viral infections, in particular respiratory syncytial viral (RSV) infections. In one aspect of the invention, there is provided compounds of the formula (I): These an additional compounds are provided which are advantageously used in methods of treating RSV wherein an effective amount of a compound or pharmaceutical compound thereof is administered to a patient in need thereof. Processes for preparing the compounds and intermediates used in their preparation are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021074196-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021074197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114929712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114945408-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578080-B2 |
| priorityDate |
2015-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |